| Discipline | Oncology, gene therapy, cell therapy |
|---|---|
| Language | English |
| Edited by | Leandro Castellano |
| Publication details | |
| History | 1994–present |
| Publisher | Nature Portfolio (United Kingdom) |
| Frequency | Monthly |
| Hybrid | |
| 6.4 (2025) | |
| Standard abbreviations | |
| ISO 4 | Cancer Gene Ther. |
| Indexing | |
| ISSN | 0929-1903 (print) 1476-5500 (web) |
| Links | |
Cancer Gene Therapy is a monthly peer-reviewed medical journal covering the use of gene therapy and cell therapy in cancer research and treatment. It is published by Nature Portfolio and was established in 1994. The editor-in-chief is Leandro Castellano.
The journal publishes laboratory and clinical research papers, review articles, brief communications, case reports, industry perspectives, and letters. Its scope includes gene-transfer technologies, viral and non-viral delivery systems, RNA interference, cancer vaccines, tumor immunology, immunotherapy, cellular therapies, cancer stem cells, tumor-suppressor genes, drug resistance, apoptosis, and DNA synthesis and repair.